Comparison of the risk of psychological and cognitive disorders between persistent and nonpersistent statin users

American Journal of Cardiology

Volumn 114, Issue 7, 2014, Pages 1035-1039

  Lilly, Steven M ^a   Mortensen, Eric M ^a   Frei, Christopher R ^b,c   Pugh, Mary Jo ^c   Mansi, Ishak A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PRAVASTATIN; ROSUVASTATIN; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIPOLAR DISORDER; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; DEMENTIA; DISEASE COURSE; FEMALE; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; OUTCOME ASSESSMENT; PHARMACY; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCHIZOPHRENIA; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; COGNITION; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; PHYSIOLOGY; PREVALENCE; PROGNOSIS; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; STATISTICS; UNITED STATES;

CARDIOVASCULAR DISEASES; COGNITION; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TEXAS;

EID: 84909608157     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.07.010     Document Type: Article

References (23)

1. K. Morales, M. Wittink, C. Datto, S. DiFilippo, M. Cary, T. TenHave, and I.R. Katz Simvastatin causes changes in affective processes in elderly volunteers J Am Geriatr Soc 54 2006 70 76
2. B.A. Golomb, T. Kane, and J.E. Dimsdale Severe irritability associated with statin cholesterol-lowering drugs QJM 97 2004 229 235
3. R.A. Stewart, K.J. Sharples, F.M. North, D.B. Menkes, J. Baker, and J. Simes Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators Arch Intern Med 160 2000 3144 3152
4. Y. Young-Xu, K.A. Chan, J.K. Liao, S. Ravid, and C.M. Blatt Long-term statin use and psychological well-being J Am Coll Cardiol 42 2003 690 697
5. J. Kugler Military Health System Patient Centered Medical Home Guide, Office of the Chief Medical Officer 2011 Tricare, Department of Defense 20
6. I. Mansi, C.R. Frei, M.J. Pugh, and E.M. Mortensen Psychologic disorders and statin use: a propensity score-matched analysis Pharmacotherapy 33 2013 615 626
7. A. Elixhauser, C. Steiner, and L. Palmer Clinical Classifications Software (CCS) for ICD-9-CM Databases and Related Tools from the Healthcare Cost and Utilization Project (HCUP) 2012 U.S. Agency for Healthcare Research and Quality Appendix A
8. A.J. Selim, G. Fincke, X.S. Ren, A. Lee, W.H. Rogers, D.R. Miller, K.M. Skinner, M. Linzer, and L.E. Kazis Comorbidity assessments based on patient report: results from the Veterans Health Study J Ambul Care Manage 27 2004 281 295
9. M. Skanderson Description of ICD-9 Comorbidity Codes Used by VACS (Veterans Aging Cohort Study) West Haven, CT 2006 1 29
10. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
11. FDA Drug Safety Communication: New Restrictions, Contraindications, and Dose Limitations for Zocor (Simvastatin) to Reduce the Risk of Muscle Injury 2011 U.S. Food and Drug Administration; U.S. Department of Health and Human Services
12. M.H. Davidson Differences between clinical trial efficacy and real-world effectiveness Am J Manag Care 12 2006 S405 S411
13. J.A. Cramer, A. Roy, A. Burrell, C.J. Fairchild, M.J. Fuldeore, D.A. Ollendorf, and P.K. Wong Medication compliance and persistence: terminology and definitions Value Health 11 2008 44 47
14. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Merz, C.B. Blum, R.H. Eckel, A.C. Goldberg, D. Gordon, D. Levy, D.M. Lloyd-Jones, P. McBride, J.S. Schwartz, S.T. Shero, S.C. Smith Jr., K. Watson, and P.W. Wilson 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 2013 10.1161/01.cir.0000437738.63853.7a E-pub ahead of print
15. P. Latry, M. Molimard, B. Dedieu, T. Couffinhal, B. Begaud, and K. Martin-Latry Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study BMC Cardiovasc Disord 11 2011 46
16. T.C. Cheetham, F. Niu, K. Green, R.D. Scott, S.F. Derose, S.S. Vansomphone, J. Shin, K. Tunceli, and K. Reynolds Primary nonadherence to statin medications in a managed care organization J Manag Care Pharm 19 2013 367 373
17. D.M. Mann, M. Woodward, P. Muntner, L. Falzon, and I. Kronish Predictors of nonadherence to statins: a systematic review and meta-analysis Ann Pharmacother 44 2010 1410 1421
18. Z. Kiss, L. Nagy, I. Reiber, G. Paragh, M.P. Molnar, G. Rokszin, Z. Abonyi-Toth, and L. Mark Persistence with statin therapy in Hungary Arch Med Sci 9 2013 409 417
19. K. Steenland, L. Zhao, F.C. Goldstein, and A.I. Levey Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment J Am Geriatr Soc 61 2013 1449 1455
20. I. Mansi, and E. Mortensen The controversy of a wider statin utilization: why? Expert Opin Drug Saf 12 2013 327 337
21. L.S. Steele, R.H. Glazier, E. Lin, and M. Evans Using administrative data to measure ambulatory mental health service provision in primary care Med Care 42 2004 960 965
22. N. Lurie, M. Popkin, M. Dysken, I. Moscovice, and M. Finch Accuracy of diagnoses of schizophrenia in Medicaid claims Hosp Community Psychiatry 43 1992 69 71
23. A. Mauskop, and W.B. Borden Predictors of statin adherence Curr Cardiol Rep 13 2011 553 558